1301.4000 -20.30 (-1.54%)
NSE Sep 22, 2025 15:31 PM
Volume: 1.4M
 

1301.40
-1.54%
Karvy
DRL's revenues rose 11.2% YoY to Rs 39.9 bn (in line with our estimates) due to better performance of US, Europe and India. Gross margins increased by 280bps YoY to 61.3% in Q2FY16 (higher than our estimates of 60%) due to strength of portfolio, business mix and yield improvement.
Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
More from Dr. Reddy's Laboratories Ltd.
Recommended